Drug ID:   | NPD1060 |
Drug Name:   | |
Molecular Formula:   | C13H17N5O2 |
Canonical SMILES:   | N=c1[nH]c2c([nH]1)n(CC1CC1)c(=O)n(c2=O)CC1CC1 |
Standard InCHI:   | InChI=1S/C13H17N5O2/c14-12-15-9-10(16-12)17(5-7-1-2-7)13(20)18(11(9)19)6-8-3-4-8/h7-8H,1-6H2,(H3,14,15,16) |
Standard InCHIKey:   | KSPYMJJKQMWWNB-UHFFFAOYSA-N |
Max Developmental Stage:   | Clinical (unspecified phase) |
Max Developmental Stage Source:   | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
Similarity Level | Similarity Score | Natural Product ID |
---|---|---|
Remote Similarity | 0.6026 | NPC326633 |
Molecular Weight   | 275.14 |
ALogP   | -0.757 |
MLogP   | 2.12 |
XLogP   | 2.257 |
HDA   | 7 |
HBD   | 3 |
Rotatable Bonds   | 4 |
TPSA   | 88.53 |
RO5 Violation   | 0 |